211 related articles for article (PubMed ID: 15201804)
1. Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis.
Ishii T; Sasaki G; Hasegawa T; Sato S; Matsuo N; Ogata T
J Urol; 2004 Jul; 172(1):319-24. PubMed ID: 15201804
[TBL] [Abstract][Full Text] [Related]
2. The effect of intramuscular testosterone enanthate treatment on stretched penile length in prepubertal boys with hypospadias.
Ishii T; Hayashi M; Suwanai A; Amano N; Hasegawa T
Urology; 2010 Jul; 76(1):97-100. PubMed ID: 20350750
[TBL] [Abstract][Full Text] [Related]
3. Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients.
Sasaki G; Ogata T; Ishii T; Kosaki K; Sato S; Homma K; Takahashi T; Hasegawa T; Matsuo N
J Clin Endocrinol Metab; 2003 Jul; 88(7):3431-6. PubMed ID: 12843198
[TBL] [Abstract][Full Text] [Related]
4. The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
Giwercman YL; Abrahamsson PA; Giwercman A; Gadaleanu V; Ahlgren G
Eur Urol; 2005 Oct; 48(4):679-85. PubMed ID: 16039774
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
Schatzl G; Madersbacher S; Gsur A; Preyer M; Haidinger G; Haitel A; Vutuc C; Micksche M; Marberger M
Prostate; 2002 Jul; 52(2):130-8. PubMed ID: 12111704
[TBL] [Abstract][Full Text] [Related]
6. [Micropenis. Results of treatment with testosterone].
Vanelli M; Bernasconi S; Terzi C; Bolondi O; Boselli E; Virdis R; Giovannelli G
Arch Fr Pediatr; 1984; 41(7):473-6. PubMed ID: 6497555
[TBL] [Abstract][Full Text] [Related]
7. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.
Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C
J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110
[TBL] [Abstract][Full Text] [Related]
8. Micropenis and the AR Gene: mutation and CAG repeat-length analysis.
Ishii T; Sato S; Kosaki K; Sasaki G; Muroya K; Ogata T; Matsuo N
J Clin Endocrinol Metab; 2001 Nov; 86(11):5372-8. PubMed ID: 11701709
[TBL] [Abstract][Full Text] [Related]
9. Testosterone therapy in microphallic hypospadias: topical or parenteral?
Chalapathi G; Rao KL; Chowdhary SK; Narasimhan KL; Samujh R; Mahajan JK
J Pediatr Surg; 2003 Feb; 38(2):221-3. PubMed ID: 12596107
[TBL] [Abstract][Full Text] [Related]
10. [Effect of (CAG) n polymorphism of androgen receptor gene on hormonal male contraception].
Li JW; Yuan D; Li H; Liang XW; Lu WH; Gu YQ
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):126-30. PubMed ID: 18390176
[TBL] [Abstract][Full Text] [Related]
11. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.
Zitzmann M
Nat Clin Pract Urol; 2007 Mar; 4(3):161-6. PubMed ID: 17347661
[TBL] [Abstract][Full Text] [Related]
13. The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
Scariano JK; Treat E; Alba F; Nelson H; Ness SA; Smith AY
Prostate; 2008 Dec; 68(16):1798-805. PubMed ID: 18780294
[TBL] [Abstract][Full Text] [Related]
14. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V. Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Kelly RW; Wu FC
J Androl; 1997; 18(4):366-71. PubMed ID: 9283948
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency.
Sinnecker GH; Hiort O; Dibbelt L; Albers N; Dörr HG; Hauss H; Heinrich U; Hemminghaus M; Hoepffner W; Holder M; Schnabel D; Kruse K
Am J Med Genet; 1996 May; 63(1):223-30. PubMed ID: 8723114
[TBL] [Abstract][Full Text] [Related]
16. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor CAG polymorphism (Xq11-12) status and human spermatogenesis: a prospective analysis of infertile males and their offspring conceived by intracytoplasmic sperm injection.
Katagiri Y; Neri QV; Takeuchi T; Moy F; Sills ES; Palermo GD
Int J Mol Med; 2006 Sep; 18(3):405-13. PubMed ID: 16865224
[TBL] [Abstract][Full Text] [Related]
18. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
[TBL] [Abstract][Full Text] [Related]
19. Timing of prepubertal androgen administration may have different effects on future fertility as well as penile size in normal male rats.
Lee H; Jin MH; Kang HJ; Hong CH; Bang WJ; Park KK; Han SW
Urology; 2010 Apr; 75(4):979-84. PubMed ID: 19896173
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development.
Choi JH; Kim GH; Seo EJ; Kim KS; Kim SH; Yoo HW
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):545-53. PubMed ID: 18717241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
